It has been reported that PPAR-γ activation reduces lipopolysaccharide-induced inflammation in a mouse model, suggesting that an activator of PPAR-γ may have a beneficial effect on the inflammatory response in COPD [36]. This evidence concerns the gene PPARG and chronic obstructive pulmonary disease.